TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q3 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $33,319,000 | +74.0% | 1,209,853 | +4.2% | 0.01% | +66.7% |
| Q1 2021 | $19,150,000 | -2.0% | 1,161,369 | +9.6% | 0.00% | 0.0% |
| Q4 2020 | $19,534,000 | +43.6% | 1,059,949 | +6.0% | 0.00% | 0.0% |
| Q3 2020 | $13,606,000 | -7.4% | 999,754 | +22.0% | 0.00% | 0.0% |
| Q2 2020 | $14,689,000 | +151.7% | 819,710 | +40.1% | 0.00% | +50.0% |
| Q1 2020 | $5,835,000 | -34.4% | 585,264 | -46.5% | 0.00% | +100.0% |
| Q4 2019 | $8,898,000 | +76.4% | 1,093,162 | +114.8% | 0.00% | 0.0% |
| Q3 2019 | $5,044,000 | +1.1% | 509,004 | +28.9% | 0.00% | 0.0% |
| Q2 2019 | $4,988,000 | +100.9% | 394,944 | +62.0% | 0.00% | 0.0% |
| Q1 2019 | $2,483,000 | +41.1% | 243,754 | +3.8% | 0.00% | – |
| Q4 2018 | $1,760,000 | +258.5% | 234,864 | +378.0% | 0.00% | – |
| Q3 2018 | $491,000 | – | 49,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,437,601 | $24,376,000 | 11.53% |
| DAFNA Capital Management LLC | 151,739 | $1,517,000 | 0.62% |
| Bain Capital Public Equity Management, LLC | 738,543 | $7,385,000 | 0.52% |
| Baupost Group | 6,491,287 | $62,393,000 | 0.48% |
| Rock Springs Capital Management LP | 1,009,179 | $10,092,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 276,639 | $2,766,000 | 0.32% |
| Cormorant Asset Management, LP | 454,550 | $4,546,000 | 0.30% |
| Artal Group S.A. | 600,000 | $6,000,000 | 0.16% |
| Perceptive Advisors | 500,000 | $5,000,000 | 0.13% |
| ArrowMark Colorado Holdings LLC | 367,744 | $3,677,000 | 0.03% |